MedPath

Sustained Therapeutics Inc

Sustained Therapeutics Inc logo
🇨🇦Canada
Ownership
-
Employees
-
Market Cap
-
Website

A Randomized, Controlled Study of Repeat Dose Sustained Release Lidocaine for Treatment of Chronic Scrotal Pain

Phase 2
Recruiting
Conditions
Chronic Pain
Interventions
Drug: 1% Lidocaine HCL
First Posted Date
2023-01-31
Last Posted Date
2025-05-16
Lead Sponsor
Sustained Therapeutics Inc.
Target Recruit Count
63
Registration Number
NCT05707208
Locations
🇨🇦

Men's Health Clinic Manitoba, Winnipeg, Manitoba, Canada

🇨🇦

THEO Medical, Montréal, Quebec, Canada

🇨🇦

Prostate Cancer Centre - Rockyview Hospital, Calgary, Alberta, Canada

and more 5 locations
© Copyright 2025. All Rights Reserved by MedPath